Jonathan S. Leventhal
Impact in
- Dermatology top 1%
- Chemotherapy-related skin toxicity
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
Papers in
- Dermatology 32
- Chemotherapy-related skin toxicity 19
- Cutaneous lymphoproliferative disorders research 8
- Oncology 34
- Cancer Immunotherapy and Biomarkers 16
- Co-authors
- Emily ColemanMelissa R. YoungMary M. TomaykoWilliam DamskyIan TattersallHarriet M. KlugerMarcus BosenbergChristine J. Ko
- Journals
- Journal of the American Academy of Dermatology (11 papers)JAMA Dermatology (6 papers)Clinics in Dermatology (4 papers)JAAD International (3 papers)British Journal of Dermatology (3 papers)
- Partner nations
- United StatesFranceNetherlands
In The Last Decade
Jonathan S. Leventhal
73 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 94
- Dermatology 374
- Oncology 718
- Transplantation 38
- Immunology 290
- Pathology and Forensic Medicine 233
Countries citing papers authored by Jonathan S. Leventhal
This map shows the geographic impact of Jonathan S. Leventhal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Leventhal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Leventhal more than expected).
Fields of papers citing papers by Jonathan S. Leventhal
This network shows the impact of papers produced by Jonathan S. Leventhal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Leventhal. The network helps show where Jonathan S. Leventhal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jonathan S. Leventhal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 11 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 40 | |
| 7 | 2023 | 18 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 5 | |
| 14 | 2020 | 10 | |
| 15 | 2020 | 24 | |
| 16 | 2019 | 57 | |
| 17 | 2018 | 15 | |
| 18 | 2017 | 15 | |
| 19 | 2017 | 36 | |
| 20 | 2017 | 7 |
About Jonathan S. Leventhal
Jonathan S. Leventhal is a scholar working on Dermatology, Oncology, Pathology and Forensic Medicine, Rheumatology and Genetics, having authored 84 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chemotherapy-related skin toxicity (19 papers), Cancer Immunotherapy and Biomarkers (16 papers), Autoimmune Bullous Skin Diseases (15 papers), Nonmelanoma Skin Cancer Studies (10 papers), Cutaneous lymphoproliferative disorders research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Drug-Induced Adverse Reactions (6 papers) and Autoimmune and Inflammatory Disorders (6 papers). The work is most often cited by research in Dermatology (374 citations), Oncology (718 citations), Transplantation (38 citations), Immunology (290 citations) and Pathology and Forensic Medicine (233 citations). Jonathan S. Leventhal has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Emily Coleman, Melissa R. Young, Mary M. Tomayko, William Damsky, Ian Tattersall, Harriet M. Kluger, Marcus Bosenberg, Christine J. Ko, Scott Gettinger and Michelle Ferreira. Their work appears in journals such as Journal of the American Academy of Dermatology, JAMA Dermatology, Clinics in Dermatology, JAAD International and British Journal of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.